JoVE Logo

Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Results
  • Discussion
  • Disclosures
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

Presented here is a useful protocol for lung fixation that creates a stable condition for histological evaluate of lung specimens from a mouse model of emphysema. The main advantage of this model is that it can fix many lungs with the same constant pressure without lung collapse or deflation.

Abstract

Emphysema is a significant feature of chronic obstructive pulmonary disease (COPD). Studies involving an emphysematous mouse model require optimal lung fixation to produce reliable histological specimens of the lung. Due to the nature of the lung’s structural composition, which consists largely of air and tissue, there is a risk that it collapses or deflates during the fixation process. Various lung fixation methods exist, each of which has its own advantages and disadvantages. The lung fixation method presented here utilizes constant pressure to enable optimal tissue evaluation for studies using an emphysematous mouse lung model. The main advantage is that it can fix many lungs with the same condition at one time. Lung specimens are obtained from chronic cigarette smoke-exposed mice. Lung fixation is performed using specialized equipment that enables the production of constant pressure. This constant pressure maintains the lung in a reasonably inflated state. Thus, this method generates a histological specimen of the lung that is suitable to evaluate cigarette smoke-induced mild emphysema.

Introduction

COPD is one of the leading worldwide causes of death1. Cigarette smoke is the most important cause of COPD, but the mechanisms of pathogenesis remain incompletely defined. COPD demonstrates two main characteristics, including progressive limitation of airflow and an abnormal inflammatory response of the lung. Emphysematous disorder frequently occurs in the lungs of COPD patients2. The pathological findings of emphysema are characterized by alveolar wall destruction3. Several animal species have been used to generate COPD models in vivo (i.e., dogs, guinea pigs, monkeys, and rodents)4. However, the mouse has become the most commonly used in the construction of COPD models. This has many advantages, including its low cost, ability to be genetically modified, extensive genomic information availability, availability of antibodies, and ability to use a variety of mouse strains5. Presently, there is no mouse model that can mimic the full features of human COPD; thus, individual researchers must choose which model is most suitable for the specific COPD research6. The emphysematous mouse model is one of many COPD mouse models that are currently available. Additional models include the exacerbation mouse model, systemic co-morbidities model, and COPD susceptibility model7.

The emphysematous mouse model can be generated by several types of exogenous agents, including chemical agents and cigarette smoke exposure4. Chemical exposure (e.g., to elastase) produces a severe type of emphysema, while cigarette smoke results in mild emphysema8,9. Cigarette smoke is believed to be the main cause for the pathogenesis of COPD; therefore, the choice of cigarette smoke as a means to create a COPD mouse model is reasonable10. Many studies have used cigarette smoke to create emphysema in the mouse. For example, Nikula et al. successfully created an emphysematous mouse model from B6C3F1 female mice by exposing them to cigarette smoke for 7 or 13 months11. We have also established an emphysematous mouse model via senescence marker protein/SMP-30 KO mice12. It is crucial to perform a lung fixation method that can properly visualize this mild emphysema model by cigarette smoke exposure.

Various methods for lung fixation have been established13. However, there is no gold standard method of lung tissue fixation for evaluating emphysema14. Several studies from this lab have shown that the fixation system presented here is useful by creating a stable condition for evaluating emphysema12,15,16,17,18. The main advantage of the current system is that it can fix many lungs with the same condition at one time without lung collapse or deflation. The current lung fixation system uses some special equipment that allows lung specimens to be inflated at an appropriate constant pressure for a given period. This special equipment consists of three parts, including a lower container, upper container, and pump. Lung specimens are placed in the lower container that is connected to pressurized fixing agents, resulting in a 25 cmH2O pressure difference in the level of agents between the upper and lower containers19.

Protocol

The following methods have been approved by the Animal Care and Use Committees of Juntendo University School of Medicine. The Guidelines for Proper Conduct of Animal Experiments, Science Council of Japan, June 1, 2006 were followed. There are three main steps in this method: 1) mouse dissection, 2) lung exsanguination, and 3) fixation of lung tissues assisted by specialized equipment. Typically, lung specimens are processed to embedment after 48 h of fixation12,15,16,17,18.

1. Mouse dissection

  1. Measure the body weight of the mouse, then determine the amount of pentobarbital to administer.
  2. Inject pentobarbital intraperitoneally at a dosage of 70 mg/kg of body weight and confirm anesthesia by the absence of reaction to toe pinch.
  3. Inject the needle at a 45° angle until it penetrates the skin and muscle. Draw the plunger and confirm an air vacuum, then inject the pentobarbital.
  4. Confirm anesthesia by the absence of reflex motion.
    NOTE: Using anesthetized mouse as opposed to a euthanized mouse is recommended for fully lung exsanguination.
  5. Cut the mouse skin and abdominal muscle at the medial line, aiming for the cephalic area.
  6. Cut laterally to provide a wider working space.

2. Lung exsanguination

  1. Expose the diaphragm layer and puncture it with forceps.
  2. Open the thoracic space and cut the sternal area, allowing the lungs and heart to be seen clearly.
  3. Cut the heart in left atrium and right ventricle.
  4. Insert a cannula (24 G) into the right ventricle area and direct it to the cephalic area until it reaches the pulmonary artery, as shown in Figure 1.
  5. Turn on the pump and allow the 1x phosphate-buffered saline (PBS) to circulate (approximately 200 mL/h) until all lung tissue changes to a white color.

3. Fixation of lung tissue

  1. Remove the trachea, lungs, and heart.
  2. Free all three organs by cutting the surrounding connective tissues.
  3. Tie the right main bronchus with a suture thread and cut all lobes of the right lung.
  4. (Optional): the lobes of the right lung consist of four parts. Cut these parts from the right main bronchus and divide the parts for processing as frozen tissue samples.
  5. Insert the heart and the lobes of the left lung into fixing agents, located inside a 10 mL syringe.
    CAUTION: Fixing agents are hazardous. Wear proper protective equipment (e.g., long rubber gloves) and work in a well-ventilated room.
  6. Create a vacuum condition using a 10 mL syringe to inflate the lung, as shown in Figure 2.
  7. Insert a cannula (20 G) into the trachea and tie a knot.
  8. Inflate the lung with fixing agents to check with for leaks, using a 1 mL syringe.
  9. Transfer to lung fixation pressure equipment, as illustrated in Figure 3.
  10. After fixing periods, remove the lung sample tying the trachea off with a knot.

Results

As described previously, the specialized equipment, which generates extended constant pressure, can be divided into three parts (Figure 3A). The lower part is the point at which to insert the lung sample (Figure 4A). The lung is connected via a cannula (20 G) to the tip of formalin flow using a three-way stop cock (Figure 4B). Pressure is generated from the different surface levels ...

Discussion

The fixation procedure for rodent lungs presented here is not novel; however, this system has several advantages. Firstly, it can fix many lungs (maximum of 20) with the same condition at one time. The Society of Toxicologic Pathology states that the pressure for gravity instillation vary from 22–25 cmH2O22. Notably, several studies have performed lung fixation at a pressure of 25 cmH2O13,19,

Disclosures

The authors have no competing interests to declare.

Acknowledgements

This work was supported in part by JSPS KAKENHI Grant Number 26461199 (T. Sato) and the Institute for Environmental and Gender-Specific Medicine, Juntendo University Graduate School of Medicine, Grant Number E2920 (T. Sato). The funder had no role in the design of the current methods and in writing the manuscript.

Materials

NameCompanyCatalog NumberComments
10% formalin (formalin neutral buffer solution)Wako060-01667
Bent forcepsHammacherHSC187-11
Cannula, size 20GTerumoSR-FS2032
Cannula, size 22GTerumoSR-OT2225CCannula to exsanguinate lung
ForcepsHammacherHSC184-10
KimtowelNippon Paper Crecia (Kimberly Clark)61000
KimwipeNippon Paper Crecia (Kimberly Clark)62011
Lower container (acrylic glass material)Tokyo ScienceCustom-madePressure equipment component
Roller pumpNissin Scientific CorpNRP-75Pump machine to exsanguinate lung
Roller pump RP-2000Eyela (Tokyo Rikakikai Co. Ltd)160200Pressure equipment pump
Silicone tube Ø 9 mmSansyo94-0479Pressure equipment component
Somnopentyl (64.8 mg/mL)Kyoritsu SeiyakuSOM02-YA1312Pentobarbital Sodium
Surgical scissorHammacherHSB014-11
Suture thread, size 0NescosutureGA01SW
Syringe, 1 mLTerumoSS-01T
Syringe, 1 ml with needleTerumoSS-01T2613S
Syringe, 10 mLTerumoSS-10ESZ
Three-way stopcockTerumoTS-TR1K01
Upper container (acrylic glass material)Tokyo ScienceCustom-madePressure equipment component

References

  1. Vogelmeier, C. F., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary. American Journal of Respiratory and Critical Care Medicine. 195 (5), 557-582 (2017).
  2. Pauwels, R. A., Rabe, K. F. Burden and clinical features of chronic obstructive pulmonary disease (COPD). Lancet. 364 (9434), 613-620 (2004).
  3. Spurzem, J. R., Rennard, S. I. Pathogenesis of COPD. Seminars in Respiratory and Critical Care Medicine. 26 (2), 142-153 (2005).
  4. Vlahos, R., Bozinovski, S., Gualano, R. C., Ernst, M., Anderson, G. P. Modelling COPD in mice. Pulmonary Pharmacology and Therapeutics. 19 (1), 12-17 (2006).
  5. Vlahos, R., Bozinovski, S. Recent advances in pre-clinical mouse models of COPD. Clinical Science (Lond). 126 (4), 253-265 (2014).
  6. Stevenson, C. S., Belvisi, M. G. Preclinical animal models of asthma and chronic obstructive pulmonary disease. Expert Review of Respiratory Medicine. 2 (5), 631-643 (2008).
  7. Stevenson, C. S., Birrell, M. A. Moving towards a new generation of animal models for asthma and COPD with improved clinical relevance. Pharmacology and Therapeutics. 130 (2), 93-105 (2011).
  8. Vandivier, R. W., Ghosh, M. Understanding the Relevance of the Mouse Cigarette Smoke Model of COPD: Peering through the Smoke. American Journal of Respiratory Cell and Molecular Biology. 57 (1), 3-4 (2017).
  9. Wright, J. L., Cosio, M., Churg, A. Animal models of chronic obstructive pulmonary disease. American Journal of Physiology Lung Cellular and Molecular Physiology. 295 (1), L1-L15 (2008).
  10. Rennard, S. I., Togo, S., Holz, O. Cigarette smoke inhibits alveolar repair: a mechanism for the development of emphysema. Proceedings of the American Thoracic Society. 3 (8), 703-708 (2006).
  11. Nikula, K. J., et al. A mouse model of cigarette smoke-induced emphysema. Chest. 117, 246S-247S (2000).
  12. Sato, T., et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. American Journal of Respiratory and Critical Care Medicine. 174 (5), 530-537 (2006).
  13. Braber, S., Verheijden, K. A., Henricks, P. A., Kraneveld, A. D., Folkerts, G. A comparison of fixation methods on lung morphology in a murine model of emphysema. American Journal of Physiology Lung Cellular and Molecular Physiology. 299 (6), L843-L851 (2010).
  14. Hsia, C. C., et al. An official research policy statement of the American Thoracic Society/European Respiratory Society: standards for quantitative assessment of lung structure. American Journal of Respiratory and Critical Care Medicine. 181 (4), 394-418 (2010).
  15. Kasagi, S., et al. Tomato juice prevents senescence-accelerated mouse P1 strain from developing emphysema induced by chronic exposure to tobacco smoke. American Journal of Physiology Lung Cellular and Molecular Physiology. 290 (2), L396-L404 (2006).
  16. Koike, K., et al. Complete lack of vitamin C intake generates pulmonary emphysema in senescence marker protein-30 knockout mice. American Journal of Physiology Lung Cellular and Molecular Physiology. 298 (6), L784-L792 (2010).
  17. Koike, K., et al. Vitamin C prevents cigarette smoke-induced pulmonary emphysema in mice and provides pulmonary restoration. American Journal of Respiratory Cell and Molecular Biology. 50 (2), 347-357 (2014).
  18. Suzuki, Y., et al. Hydrogen-rich pure water prevents cigarette smoke-induced pulmonary emphysema in SMP30 knockout mice. Biochemical and Biophysical Research Communications. 492 (1), 74-81 (2017).
  19. Saad, M., Ruwanpura, S. M. Tissue Processing for Stereological Analyses of Lung Structure in Chronic Obstructive Pulmonary Disease. Methods in Molecular Biology. 1725, 155-162 (2018).
  20. Thurlbeck, W. M. The internal surface area of nonemphysematous lungs. The American Review of Respiratory Disease. 95 (5), 765-773 (1967).
  21. Saetta, M., et al. Destructive index: a measurement of lung parenchymal destruction in smokers. The American Review of Respiratory Disease. 131 (5), 764-769 (1985).
  22. Renne, R., et al. Recommendation of optimal method for formalin fixation of rodent lungs in routine toxicology studies. Toxicologic Pathology. 29 (5), 587-589 (2001).
  23. Schneider, J. P., Ochs, M. Alterations of mouse lung tissue dimensions during processing for morphometry: a comparison of methods. American Journal of Physiology Lung Cellular and Molecular Physiology. 306 (4), L341-L350 (2014).
  24. Wright, J. L. Relationship of pulmonary arterial pressure and airflow obstruction to emphysema. Journal of Applied Physiology. 74 (3), 1320-1324 (1993).
  25. Wright, J. L., Churg, A. Cigarette smoke causes physiologic and morphologic changes of emphysema in the guinea pig. The American Review of Respiratory Disease. 142 (6 Pt 1), 1422-1428 (1990).
  26. Thurlbeck, W. M. Internal surface area and other measurements in emphysema. Thorax. 22 (6), 483-496 (1967).
  27. Wright, J. L., et al. Airway remodeling in the smoke exposed guinea pig model. Inhalation Toxicology. 19 (11), 915-923 (2007).
  28. Limjunyawong, N., Mock, J., Mitzner, W. Instillation and Fixation Methods Useful in Mouse Lung Cancer Research. Journal of Visualized Experiments. (102), e52964 (2015).
  29. Roos, A. B., Berg, T., Ahlgren, K. M., Grunewald, J., Nord, M. A method for generating pulmonary neutrophilia using aerosolized lipopolysaccharide. Journal of Visualized Experiments. (94), (2014).
  30. Laucho-Contreras, M. E., Taylor, K. L., Mahadeva, R., Boukedes, S. S., Owen, C. A. Automated measurement of pulmonary emphysema and small airway remodeling in cigarette smoke-exposed mice. Journal of Visualized Experiments. (95), 52236 (2015).
  31. Nakanishi, Y., et al. Clarithromycin prevents smoke-induced emphysema in mice. American Journal of Respiratory and Critical Care Medicine. 179 (4), 271-278 (2009).
  32. Maeno, T., et al. CD8+ T Cells are required for inflammation and destruction in cigarette smoke-induced emphysema in mice. Journal of Immunology. 178 (12), 8090-8096 (2007).
  33. Sato, M., et al. Optimal fixation for total preanalytic phase evaluation in pathology laboratories: a comprehensive study including immunohistochemistry, DNA, and mRNA assays. Pathology International. 64 (5), 209-216 (2014).

Reprints and Permissions

Request permission to reuse the text or figures of this JoVE article

Request Permission

Explore More Articles

Lung FixationConstant PressureEmphysemaMiceHistologyCigarette SmokePulmonaryPerfusionPBSFixativeTracheaLung SpecimenLung Fixation Pressure Equipment

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2025 MyJoVE Corporation. All rights reserved